CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: long-chain fatty alcohol
Accession: CHEBI:17135
browse the term
Definition: A fatty alcohol with a chain length ranging from C13 to C22.
Synonyms: related_synonym: Formula=HOR; Long-chain alcohol; SMILES=O[*]; a long chain fatty alcohol; long chain fatty alcohols; long-chain alcohols
alt_id: CHEBI:14527; CHEBI:6524; CHEBI:73312
xref: KEGG:C00339; MetaCyc:Long-chain-alcohols; PMID:19155068; PMID:22436224; PMID:22444994
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
EXP
falcarinol results in decreased expression of BAX protein
CTD
PMID:19800326
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression
EXP
falcarinol results in increased expression of BCL2 protein
CTD
PMID:19800326
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions decreases expression
EXP
falcarinol results in decreased expression of and results in decreased activity of CASP3 protein falcarinol results in decreased expression of CASP3 protein modified form
CTD
PMID:19800326
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
falcarinol inhibits the reaction [PDGFB protein results in increased phosphorylation of CREB1 protein]
CTD
PMID:18199429
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
ISO
Panaxynol inhibits the reaction [Chronic unpredictable mild stress decreases expression of Gria1 protein in the hippocampal formation]
RGD
PMID:32048672
RGD:405849038
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
EXP
falcarinol results in increased expression of HIF1A protein
CTD
PMID:19800326
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
falcarinol inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:18199429
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
falcarinol inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:18199429
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Pdgfb
platelet derived growth factor subunit B
multiple interactions
EXP
falcarinol inhibits the reaction [PDGFB protein results in increased phosphorylation of CREB1 protein]; falcarinol inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; falcarinol inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:18199429
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions
ISO
[perifosine co-treated with Butyrates] results in increased secretion of AIFM1 protein; [perifosine co-treated with trichostatin A] results in increased secretion of AIFM1 protein; [perifosine co-treated with vorinostat] results in increased secretion of AIFM1 protein
CTD
PMID:15781658
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO
[perifosine co-treated with Butyrates] results in decreased activity of AKT1 protein; [perifosine co-treated with trichostatin A] results in decreased activity of AKT1 protein; [perifosine co-treated with Vorinostat] results in decreased activity of AKT1 protein; AKT1 protein modified form results in decreased activity of [perifosine co-treated with Butyrates]; AKT1 protein modified form results in decreased activity of [perifosine co-treated with trichostatin A]; AKT1 protein modified form results in decreased activity of [perifosine co-treated with Vorinostat]; perifosine inhibits the reaction [cyadox results in increased phosphorylation of AKT1 protein] [perifosine co-treated with temsirolimus] results in decreased activity of AKT1 protein perifosine results in decreased phosphorylation of AKT1 protein
CTD
PMID:15781658 PMID:21267448 PMID:30265530 PMID:31445927
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bak1
BCL2-antagonist/killer 1
multiple interactions
ISO
[perifosine co-treated with Butyrates] results in decreased expression of BAK1 protein; [perifosine co-treated with trichostatin A] results in decreased expression of BAK1 protein; [perifosine co-treated with vorinostat] results in decreased expression of BAK1 protein
CTD
PMID:15781658
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[perifosine co-treated with Butyrates] results in increased activity of BAX protein; [perifosine co-treated with trichostatin A] results in increased activity of BAX protein; [perifosine co-treated with vorinostat] results in increased activity of BAX protein
CTD
PMID:15781658
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Casp3
caspase 3
multiple interactions decreases expression
ISO
[perifosine co-treated with Butyrates] results in increased activity of CASP3 protein; [perifosine co-treated with trichostatin A] results in increased activity of CASP3 protein; [perifosine co-treated with vorinostat] results in increased activity of CASP3 protein perifosine results in decreased expression of CASP3 protein
CTD
PMID:15781658 PMID:25416439
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases expression
ISO
[perifosine co-treated with Butyrates] results in increased activity of CASP8 protein; [perifosine co-treated with trichostatin A] results in increased activity of CASP8 protein; [perifosine co-treated with Vorinostat] results in increased activity of CASP8 protein; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [perifosine results in increased expression of CASP8 protein modified form]; LAT2 protein inhibits the reaction [perifosine results in increased expression of CASP8 protein modified form]
CTD
PMID:15781658 PMID:32587277
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
perifosine inhibits the reaction [Mitomycin results in increased expression of CDKN1A protein]
CTD
PMID:34624459
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
[perifosine co-treated with Butyrates] affects the localization of CYCS protein; [perifosine co-treated with trichostatin A] affects the localization of CYCS protein; [perifosine co-treated with vorinostat] affects the localization of CYCS protein
CTD
PMID:15781658
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Egf
epidermal growth factor
multiple interactions
ISO
perifosine inhibits the reaction [cyadox results in increased expression of EGF]; perifosine inhibits the reaction [Hydrogen Peroxide results in increased expression of EGF]
CTD
PMID:30265530
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Fas
Fas cell surface death receptor
affects response to substance
ISO
perifosine affects the susceptibility to FAS protein
CTD
PMID:31445927
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Foxo1
forkhead box O1
multiple interactions
ISO
[perifosine co-treated with cyadox] results in increased expression of FOXO1 mRNA; [perifosine co-treated with Hydrogen Peroxide] results in increased expression of FOXO1 mRNA perifosine inhibits the reaction [cyanoginosin LR results in increased phosphorylation of FOXO1 protein]
CTD
PMID:30265530 PMID:33078829
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Glb1
galactosidase, beta 1
multiple interactions
ISO
perifosine inhibits the reaction [Mitomycin results in increased activity of GLB1 protein]
CTD
PMID:34624459
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Lat2
linker for activation of T cells family, member 2
multiple interactions decreases expression decreases response to substance
ISO
ixazomib inhibits the reaction [perifosine results in decreased expression of LAT2 protein]; LAT2 protein inhibits the reaction [perifosine results in increased cleavage of PARP1 protein]; LAT2 protein inhibits the reaction [perifosine results in increased expression of CASP8 protein modified form] LAT2 protein results in decreased susceptibility to perifosine
CTD
PMID:23001822 PMID:32587277
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
MAP2K1 protein mutant form results in decreased activity of [perifosine co-treated with Butyrates]; MAP2K1 protein mutant form results in decreased activity of [perifosine co-treated with trichostatin A]; MAP2K1 protein mutant form results in decreased activity of [perifosine co-treated with vorinostat]
CTD
PMID:15781658
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
[perifosine co-treated with Butyrates] results in decreased activity of MAPK1 protein; [perifosine co-treated with trichostatin A] results in decreased activity of MAPK1 protein; [perifosine co-treated with vorinostat] results in decreased activity of MAPK1 protein
CTD
PMID:15781658
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
[perifosine co-treated with Butyrates] results in decreased activity of MAPK3 protein; [perifosine co-treated with trichostatin A] results in decreased activity of MAPK3 protein; [perifosine co-treated with vorinostat] results in decreased activity of MAPK3 protein
CTD
PMID:15781658
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
[perifosine co-treated with Butyrates] results in increased activity of MAPK8 protein; [perifosine co-treated with trichostatin A] results in increased activity of MAPK8 protein; [perifosine co-treated with vorinostat] results in increased activity of MAPK8 protein
CTD
PMID:15781658
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
[perifosine co-treated with temsirolimus] results in decreased activity of MTOR protein
CTD
PMID:21267448
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [perifosine results in increased cleavage of PARP1 protein]; LAT2 protein inhibits the reaction [perifosine results in increased cleavage of PARP1 protein]
CTD
PMID:32587277
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Tnf
tumor necrosis factor
increases response to substance
ISO
perifosine results in increased susceptibility to TNF protein
CTD
PMID:31445927
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
perifosine inhibits the reaction [cyadox results in increased expression of TP53 mRNA]; perifosine inhibits the reaction [cyadox results in increased expression of TP53 protein]; perifosine inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 mRNA]
CTD
PMID:30265530
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
increases expression multiple interactions
ISO
Phytol results in increased expression of ALDH3A2 protein PPARA protein affects the reaction [Phytol results in increased expression of ALDH3A2 protein]
CTD
PMID:17015885
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
Phytol inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein]
CTD
PMID:30520250
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
Phytol inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]
CTD
PMID:30520250
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
ISO
Phytol inhibits the reaction [Benzo(a)pyrene results in increased expression of CASP3 protein]
CTD
PMID:30520250
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
[Phytol co-treated with Benzo(a)pyrene] results in decreased expression of CASP9 protein
CTD
PMID:30520250
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases expression multiple interactions
ISO
Phytol results in increased expression of CAT Phytol inhibits the reaction [Benzo(a)pyrene results in increased expression of CAT protein]
CTD
PMID:19188468 PMID:30520250
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
Phytol inhibits the reaction [Benzo(a)pyrene results in increased expression of GSR protein]
CTD
PMID:30520250
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine affects the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK1 protein]]; Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK1 protein]
CTD
PMID:29486182
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine affects the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK3 protein]]; Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK3 protein]
CTD
PMID:29486182
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mitf
melanocyte inducing transcription factor
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]] which results in decreased ubiquitination of MITF protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]]; [Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]] which results in decreased ubiquitination of MITF protein; Acetylcysteine inhibits the reaction [Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]] which results in decreased ubiquitination of MITF protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]]; Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]
CTD
PMID:29486182
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Ppara
peroxisome proliferator activated receptor alpha
affects metabolic processing multiple interactions
ISO
PPARA protein affects the metabolism of Phytol PPARA protein affects the reaction [Phytol results in increased expression of ALDH3A2 protein]
CTD
PMID:17015885
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1b
PPARG coactivator 1 beta
increases activity
ISO
Phytol results in increased activity of PPARGC1B protein
CTD
PMID:17015885
NCBI chr18:54,758,891...54,861,103
Ensembl chr18:54,758,902...54,861,194
G
Tyr
tyrosinase
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytol inhibits the reaction [alpha-MSH results in increased expression of TYR protein]]; Phytol inhibits the reaction [alpha-MSH results in increased expression of TYR protein]
CTD
PMID:29486182
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Tyrp1
tyrosinase-related protein 1
multiple interactions
ISO
Phytol inhibits the reaction [alpha-MSH results in increased expression of TYRP1 protein]
CTD
PMID:29486182
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19874
chemical entity
19872
molecular entity
19872
polyatomic entity
19824
heteroatomic molecular entity
19781
hydroxides
19341
organic hydroxy compound
18951
alcohol
15716
fatty alcohol
6135
long-chain fatty alcohol
35
(+)-6-Hydroxysporotricale, open form
0
(+)-sporotricale
0
(2E,5E,12Z,15Z)-1-Hydroxy-2,5,12,15-heneicosatetraen-4-one
0
(2S,3S,4S)-5,7,9,11-Tridecatetrayne-1,2,3,4-tetrol
0
(3R,9E)-heptadeca-1,9-diene-4,6-diyn-3-ol
0
(3S,10S)-panaxydiol
0
(3S,6S,7S,10R)-3,7-dihydroxy-15-[3-hydroxy-5-(hydroxymethyl)phenyl]-10-methoxy-4,6,14-trimethyl-9-oxopentadeca-4,11,13-trienoic acid
0
(3S,9R,10R)-gensenoyne C
0
(3S,9R,10R)-panaxytriol
0
(3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol
0
(5E)-Heptadeca-5,16-diene-1,2,4-triol
0
(5R,8R,11R)-d9-4-NeuroF[4S,7R]
0
(9Z,11S,16S)-1-Acetoxy-9,17-octadecadiene-12,14-diyne-11,16-diol
0
(E)-2-Tridecene-4,6,8-triyn-1-ol
0
(R)-2-hydroxy-6-(12-hydroxyheptadecyl)benzoic acid
0
(R)-2-hydroxy-6-(14-hydroxypentadecyl)benzoic acid
0
(R)-3,5-dihydroxy-7-(15-hydroxyheptadecyl)benzoic acid
0
(R)-3,5-dihydroxy-7-(16-hydroxyheptadecyl)benzoic acid
0
(S)-13-Methyltetradecan-2-ol
0
(all-E)-1,8,10-Heptadecatriene-4,6-diyne-3,12-diol
0
(all-E)-3,5,7-Tridecatriene-9,11-diyn-1-ol
0
1,17-Heptadecanediol
0
1,2,4-Nonadecanetriol
0
1,2-nonadecanediol
0
1,20-Eicosanediol
0
1,21-Heneicosanediol
0
1,4-Epoxy-16-hydroxyheneicos-1,3,12,14-tetraene
0
1,8-Heptadecadiene-4,6-diyne-3,10-diol
0
1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-one
0
1-Acetoxy-2-hydroxy-16-heptadecen-4-one
0
1-Acetoxy-2-hydroxy-16-heptadecyn-4-one
0
1-Acetoxy-2-hydroxy-5,12,15-heneicosatrien-4-one
0
1-Heptadecene-4,6-diyne-3,9-diol
0
1-O-(2R-hydroxy-4Z-heicosenyl)-sn-glycerol
0
1-O-(2R-hydroxy-4Z-hexadecenyl)-sn-glycerol
0
1-O-(2R-hydroxy-4Z-pentadecenyl)-sn-glycerol
0
1-O-(2R-hydroxy-4Z-tetradecenyl)-sn-glycerol
0
1-O-(2R-hydroxy-eicosanyl)-sn-glycerol
0
1-O-(2R-hydroxy-heneicosanyl)-sn-glycerol
0
1-O-(2R-hydroxy-hexadecyl)-sn-glycerol
0
1-O-(2R-hydroxy-octadecyl)-sn-glycerol
0
1-O-(2R-hydroxy-pentadecyl)-sn-glycerol
0
1-O-(2R-hydroxy-tetradecyl)-sn-glycerol
0
1-Stearoylglycerol
0
10-Acetoxy-8-heptadecene-4,6-diyn-3-ol
0
10-Acetylpanaxytriol
0
10-propyl-5,9-tridecadien-1-ol
0
10E,12E-Hexadecadien-1-ol
0
10E,12E-Tetradecadien-1-ol
0
10Z,12Z-Tetradecadien-1-ol
0
11E,13-Tetradecadien-1-ol
0
11E,13E-Hexadecadien-1-ol
0
11E,13Z-Hexadecadien-1-ol
0
11E-Eicosen-1-ol
0
11E-Hexadecen-1-ol
0
11E-Tetradecen-1-ol
0
11Z,13E-Hexadecadien-1-ol
0
11Z,13Z-Hexadecadien-1-ol
0
11Z-heptadecen-1-ol
0
11Z-hexadecen-1-ol
0
13-Heptadecyn-1-ol
0
13-Tetradece-11-yn-1-ol
0
13-tetradecen-2,4-diyn-1-ol
0
13Z-Hexadecen-11-yn-1-ol
0
14-(2',3',5'-Trihydroxyphenyl)tetradecan-2-ol
0
14-methyl-8-hexadecen-1-ol
0
15-Hydroxy-1-(2,4,6-trihydroxyphenyl)-5Z,8Z,11Z,13E,17Z-eicosapentaen-1-one
0
15-Nonacosanol
0
15-methylheneicosane-1,2-diol
0
15Z-Eicosen-1-ol
0
17-OCTADECEN-14-YN-1-OL
0
18R-hydroxydihydroalloprotolichesterinic acid
0
18S-hydroxydihydroprotolichesterinic acid
0
18S-hydroxyneodihydroprotolichesterinic acid
0
2,18-seco-lankacidinol B
0
2,4-dihydroxyheptadec-16-enyl acetate
0
2,4-dihydroxyheptadecyl acetate
0
2,6,8,12-Tetramethyl-2,4-tridecadien-1-ol
0
2-Cyclohexen-1-one, 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-
0
2-hydroxy-6-((R,8Z,11Z)-14-hydroxyheptadeca-8,11-dien-1-yl)benzoic acid
0
23-Dihydroxy-2-(1-hydroxytridecyl)-4-met
0
3-Hydroxy-1-phenyl-1-eicosanone
0
3-Hydroxy-1-phenyl-1-heptadecanone
0
3-Hydroxy-1-phenyl-1-octadecanone
0
3E,13Z-Octadecadien-1-ol
0
3E-Tetradecen-1-ol
0
3S,7S-dimethyl-2-hexadecanol
0
3S,7S-dimethyl-2S-tetradecanol
0
3Z,13Z-octadecadien-1-ol
0
4,5-epoxy-17R-HDHA
0
4-Hydroxy-6-docosanone
0
4-Hydroxy-6-eicosanone
0
4-Hydroxy-6-heneicosanone
0
4-Hydroxy-6-nonadecanone
0
4-Hydroxy-6-tetracosanone
0
4-O-acetyl hygrophorone A12
0
4-O-acetyl hygrophorone A14
0
4E,6E,10Z-Hexadecatrien-1-ol
0
4E,6Z,10Z-Hexadecatrien-1-ol
0
4E,6Z-Hexadecadien-1-ol
0
5,10-Pentadecadien-1-ol
0
5,6-Dihydroxy-8Z,11Z,14Z-eicosatrienoic acid, 1,5-lactone
0
5-Hydroxy-7-docosanone
0
5-Hydroxy-7-eicosanone
0
5-Hydroxy-7-tetracosanone
0
6-((2S,4R)-2,4,11-trihydroxyundecyl)-4-hydroxy-3-methyl-2H-pyran-2-one
0
6-((Z)-14-hydroxypentadec-8-en-1-yl)salicylic acid
0
6-Hydroxy-(E,E)-7,9-heneicosadien-11-one
0
6-Hydroxy-4-heneicosanone
0
6-Hydroxy-4-nonadecanone
0
6-Hydroxy-8-docosanone
0
6-Hydroxy-8-heneicosanone
0
6-Hydroxy-8-tricosanone
0
6-hydroxysporotricale
0
6E,11Z-hexadecadien-1-ol
0
6Z,11Z-hexadecadien-1-ol
0
7,11-hexadecadien-1-ol
0
7-Hexadecen-1-ol
0
7Z,11E-Hexadecadien-1-ol
0
7Z,11Z-Hexadecadien-1-ol
0
7Z-hexadecen-1-ol
0
8-Hydroxy-6-docosanone
0
8-Hydroxy-6-heneicosanone
0
8E,10E-Tetradecadien-1-ol
0
8Z,10E-Tetradecadien-1-ol
0
9,12,15-Octadecatrien-1-ol
0
9-Hexadecen-1-ol
0
9-Pentadecen-1-ol
0
9-Pentadecene-12,14-diyne-1,11-diol
0
9Z,11E-Tetradecadien-1-ol
0
9Z,11Z-Tetradecadien-1-ol
0
9Z,12E-Tetradecadien-1-ol
0
9Z,12Z-Tetradecadien-1-ol
0
9Z-Tetradecen-1-ol
0
Actinofuranone D
0
Actinofuranone E
0
Actinofuranone F
0
Actinofuranone G
0
Actinofuranone H
0
Actinofuranone I
0
Allo-murolic acid
0
Atractylentrid
0
Avocadene
0
Avocadene 2-acetate
0
Avocadene 4-acetate
0
Avocadyne
0
Avocadyne 1-acetate
0
Avocadyne 2-acetate
0
Avocadyne 4-acetate
0
Baulamycin A
0
Baulamycin B
0
Benquinol
0
Bupleuonol
0
CJ-13,104
0
Chivotriene
0
Cicutoxin
0
Cystochromone C
0
DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
0
DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
0
DG(15:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
0
DG(18:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
0
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/16:0/0:0)
0
Daldispone B
0
Dehydrofalcarinol
0
Dehydrosafynol
0
Dihydropanaxacol
0
E-975
0
Enanthotoxin
0
Erythro-6,8-Tricosanediol
0
F-36316 B
0
F-36316 C
0
Ginsenoyne C
0
Ginsenoyne J
0
Ginsenoyne K
0
Hansfordiol A
0
Hansfordiol C
0
Hansfordiol D
0
Hansfordiol E
0
Hansfordiol G
0
Haplofungin A
0
Haplofungin B
0
Haplofungin C
0
Haplofungin D
0
Haplofungin E
0
Haplofungin F
0
Haplofungin G
0
Haplofungin H
0
Harzianumol G
0
Harzianumol H
0
Henicosane-6,8-diol
0
Hyafurone A1
0
Hyafurone A2
0
Hyafurone B
0
Hyapyrone A
0
Hyapyrone B
0
Hygrophoron B14
0
Hygrophorone A12
0
Hygrophorone B14
0
Hygrophorone B16
0
Hygrophorone F12
0
Hygrophorone G12
0
Isomurolic acid
0
LSM-4429
0
Leptolyngbyalide B
0
Leptolyngbyalide C
0
Linfuranone B
0
Linfuranone C
0
Linieodolide A
0
Loseolamycin A2
0
Macrolactin U
0
Marinisporolide A
0
Merulinic acid B
0
Methyl (2E)-2-(1-hydroxy-2-oxopropyl)-2-hexadecenoate
0
Methyl-[12]-gingerdiol
0
Momordol
0
Muricatacin
0
Murolic acid
0
Panaxjapyne A
0
Panaxjapyne B
0
Panaxjapyne C
0
Panaxynol
9
Panaxytriol
0
Penicilloitin B
0
Penitalarin B
0
Penitalarin C
0
Penixylarin C
0
Penostatin E
0
Persediene
0
Persenone A
0
Persenone B
0
Persenone C
0
Persin
0
Phanerosporic acid
0
Phomopoxide A
0
Phomopoxide B
0
Phomopoxide D
0
Phomopoxide E
0
Protoconstipatic acid
0
Ratjadone B
0
Ratjadone C
0
SNF-4794-7
0
SNF-4794-9
0
Safynol
0
Separacene A
0
Separacene B
0
Separacene C
0
Separacene D
0
Seselidiol
0
Succinilene A
0
Succinilene B
0
Succinilene C
0
Succinilene D
0
TM-124
0
Tanikolide
0
Tetrahydropersin
0
Trihazone B
0
Trihazone E
0
Virol A
0
Virol B
0
Z-10-Pentadecenol
0
[(2R)-2,3-dihydroxypropyl] (2E,4E,8E,13S)-13-hydroxytetradeca-2,4,8-trienoate
0
[(2S)-2,3-dihydroxypropyl] (2E,4E,8E,13S)-13-hydroxytetradeca-2,4,8-trienoate
0
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate
0
cis-Annonacin-10-one
0
fatty alcohol 13:0 +
0
fatty alcohol 13:1
0
fatty alcohol 14:0 +
0
fatty alcohol 14:1
0
fatty alcohol 15:0 +
0
fatty alcohol 15:1
0
fatty alcohol 16:0 +
0
fatty alcohol 16:1
0
fatty alcohol 17:0 +
0
fatty alcohol 17:1
0
fatty alcohol 18:0 +
21
fatty alcohol 18:1 +
0
fatty alcohol 18:2 +
0
fatty alcohol 18:3
0
fatty alcohol 19:0 +
0
fatty alcohol 20:0 +
0
fatty alcohol 20:1 +
0
fatty alcohol 20:2
0
fatty alcohol 21:0 +
0
fatty alcohol 22:0 +
0
fatty alcohol 22:1 +
0
fatty alcohol 22:2
0
hentriacontan-16-ol
0
iso-1,2-nonadecanediol
0
long-chain primary fatty alcohol +
31
methyl-2,3,5-trihydroxytetradecanoate
0
panaquinquecol 1
0
tridecanol +
0
Path 2
CHEBI ontology
19874
subatomic particle
19872
composite particle
19872
hadron
19872
baryon
19872
nucleon
19872
atomic nucleus
19872
atom
19872
main group element atom
19811
p-block element atom
19811
carbon group element atom
19751
carbon atom
19748
organic molecular entity
19748
heteroorganic entity
19505
organochalcogen compound
19268
organooxygen compound
19184
carbon oxoacid
18654
carboxylic acid
18651
monocarboxylic acid
18000
fatty acid
16833
fatty acid derivative
8980
fatty alcohol
6135
long-chain fatty alcohol
35
(+)-6-Hydroxysporotricale, open form
0
(+)-sporotricale
0
(2E,5E,12Z,15Z)-1-Hydroxy-2,5,12,15-heneicosatetraen-4-one
0
(2S,3S,4S)-5,7,9,11-Tridecatetrayne-1,2,3,4-tetrol
0
(3R,9E)-heptadeca-1,9-diene-4,6-diyn-3-ol
0
(3S,10S)-panaxydiol
0
(3S,6S,7S,10R)-3,7-dihydroxy-15-[3-hydroxy-5-(hydroxymethyl)phenyl]-10-methoxy-4,6,14-trimethyl-9-oxopentadeca-4,11,13-trienoic acid
0
(3S,9R,10R)-gensenoyne C
0
(3S,9R,10R)-panaxytriol
0
(3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol
0
(5E)-Heptadeca-5,16-diene-1,2,4-triol
0
(5R,8R,11R)-d9-4-NeuroF[4S,7R]
0
(9Z,11S,16S)-1-Acetoxy-9,17-octadecadiene-12,14-diyne-11,16-diol
0
(E)-2-Tridecene-4,6,8-triyn-1-ol
0
(R)-2-hydroxy-6-(12-hydroxyheptadecyl)benzoic acid
0
(R)-2-hydroxy-6-(14-hydroxypentadecyl)benzoic acid
0
(R)-3,5-dihydroxy-7-(15-hydroxyheptadecyl)benzoic acid
0
(R)-3,5-dihydroxy-7-(16-hydroxyheptadecyl)benzoic acid
0
(S)-13-Methyltetradecan-2-ol
0
(all-E)-1,8,10-Heptadecatriene-4,6-diyne-3,12-diol
0
(all-E)-3,5,7-Tridecatriene-9,11-diyn-1-ol
0
1,17-Heptadecanediol
0
1,2,4-Nonadecanetriol
0
1,2-nonadecanediol
0
1,20-Eicosanediol
0
1,21-Heneicosanediol
0
1,4-Epoxy-16-hydroxyheneicos-1,3,12,14-tetraene
0
1,8-Heptadecadiene-4,6-diyne-3,10-diol
0
1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-one
0
1-Acetoxy-2-hydroxy-16-heptadecen-4-one
0
1-Acetoxy-2-hydroxy-16-heptadecyn-4-one
0
1-Acetoxy-2-hydroxy-5,12,15-heneicosatrien-4-one
0
1-Heptadecene-4,6-diyne-3,9-diol
0
1-O-(2R-hydroxy-4Z-heicosenyl)-sn-glycerol
0
1-O-(2R-hydroxy-4Z-hexadecenyl)-sn-glycerol
0
1-O-(2R-hydroxy-4Z-pentadecenyl)-sn-glycerol
0
1-O-(2R-hydroxy-4Z-tetradecenyl)-sn-glycerol
0
1-O-(2R-hydroxy-eicosanyl)-sn-glycerol
0
1-O-(2R-hydroxy-heneicosanyl)-sn-glycerol
0
1-O-(2R-hydroxy-hexadecyl)-sn-glycerol
0
1-O-(2R-hydroxy-octadecyl)-sn-glycerol
0
1-O-(2R-hydroxy-pentadecyl)-sn-glycerol
0
1-O-(2R-hydroxy-tetradecyl)-sn-glycerol
0
1-Stearoylglycerol
0
10-Acetoxy-8-heptadecene-4,6-diyn-3-ol
0
10-Acetylpanaxytriol
0
10-propyl-5,9-tridecadien-1-ol
0
10E,12E-Hexadecadien-1-ol
0
10E,12E-Tetradecadien-1-ol
0
10Z,12Z-Tetradecadien-1-ol
0
11E,13-Tetradecadien-1-ol
0
11E,13E-Hexadecadien-1-ol
0
11E,13Z-Hexadecadien-1-ol
0
11E-Eicosen-1-ol
0
11E-Hexadecen-1-ol
0
11E-Tetradecen-1-ol
0
11Z,13E-Hexadecadien-1-ol
0
11Z,13Z-Hexadecadien-1-ol
0
11Z-heptadecen-1-ol
0
11Z-hexadecen-1-ol
0
13-Heptadecyn-1-ol
0
13-Tetradece-11-yn-1-ol
0
13-tetradecen-2,4-diyn-1-ol
0
13Z-Hexadecen-11-yn-1-ol
0
14-(2',3',5'-Trihydroxyphenyl)tetradecan-2-ol
0
14-methyl-8-hexadecen-1-ol
0
15-Hydroxy-1-(2,4,6-trihydroxyphenyl)-5Z,8Z,11Z,13E,17Z-eicosapentaen-1-one
0
15-Nonacosanol
0
15-methylheneicosane-1,2-diol
0
15Z-Eicosen-1-ol
0
17-OCTADECEN-14-YN-1-OL
0
18R-hydroxydihydroalloprotolichesterinic acid
0
18S-hydroxydihydroprotolichesterinic acid
0
18S-hydroxyneodihydroprotolichesterinic acid
0
2,18-seco-lankacidinol B
0
2,4-dihydroxyheptadec-16-enyl acetate
0
2,4-dihydroxyheptadecyl acetate
0
2,6,8,12-Tetramethyl-2,4-tridecadien-1-ol
0
2-Cyclohexen-1-one, 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-
0
2-hydroxy-6-((R,8Z,11Z)-14-hydroxyheptadeca-8,11-dien-1-yl)benzoic acid
0
23-Dihydroxy-2-(1-hydroxytridecyl)-4-met
0
3-Hydroxy-1-phenyl-1-eicosanone
0
3-Hydroxy-1-phenyl-1-heptadecanone
0
3-Hydroxy-1-phenyl-1-octadecanone
0
3E,13Z-Octadecadien-1-ol
0
3E-Tetradecen-1-ol
0
3S,7S-dimethyl-2-hexadecanol
0
3S,7S-dimethyl-2S-tetradecanol
0
3Z,13Z-octadecadien-1-ol
0
4,5-epoxy-17R-HDHA
0
4-Hydroxy-6-docosanone
0
4-Hydroxy-6-eicosanone
0
4-Hydroxy-6-heneicosanone
0
4-Hydroxy-6-nonadecanone
0
4-Hydroxy-6-tetracosanone
0
4-O-acetyl hygrophorone A12
0
4-O-acetyl hygrophorone A14
0
4E,6E,10Z-Hexadecatrien-1-ol
0
4E,6Z,10Z-Hexadecatrien-1-ol
0
4E,6Z-Hexadecadien-1-ol
0
5,10-Pentadecadien-1-ol
0
5,6-Dihydroxy-8Z,11Z,14Z-eicosatrienoic acid, 1,5-lactone
0
5-Hydroxy-7-docosanone
0
5-Hydroxy-7-eicosanone
0
5-Hydroxy-7-tetracosanone
0
6-((2S,4R)-2,4,11-trihydroxyundecyl)-4-hydroxy-3-methyl-2H-pyran-2-one
0
6-((Z)-14-hydroxypentadec-8-en-1-yl)salicylic acid
0
6-Hydroxy-(E,E)-7,9-heneicosadien-11-one
0
6-Hydroxy-4-heneicosanone
0
6-Hydroxy-4-nonadecanone
0
6-Hydroxy-8-docosanone
0
6-Hydroxy-8-heneicosanone
0
6-Hydroxy-8-tricosanone
0
6-hydroxysporotricale
0
6E,11Z-hexadecadien-1-ol
0
6Z,11Z-hexadecadien-1-ol
0
7,11-hexadecadien-1-ol
0
7-Hexadecen-1-ol
0
7Z,11E-Hexadecadien-1-ol
0
7Z,11Z-Hexadecadien-1-ol
0
7Z-hexadecen-1-ol
0
8-Hydroxy-6-docosanone
0
8-Hydroxy-6-heneicosanone
0
8E,10E-Tetradecadien-1-ol
0
8Z,10E-Tetradecadien-1-ol
0
9,12,15-Octadecatrien-1-ol
0
9-Hexadecen-1-ol
0
9-Pentadecen-1-ol
0
9-Pentadecene-12,14-diyne-1,11-diol
0
9Z,11E-Tetradecadien-1-ol
0
9Z,11Z-Tetradecadien-1-ol
0
9Z,12E-Tetradecadien-1-ol
0
9Z,12Z-Tetradecadien-1-ol
0
9Z-Tetradecen-1-ol
0
Actinofuranone D
0
Actinofuranone E
0
Actinofuranone F
0
Actinofuranone G
0
Actinofuranone H
0
Actinofuranone I
0
Allo-murolic acid
0
Atractylentrid
0
Avocadene
0
Avocadene 2-acetate
0
Avocadene 4-acetate
0
Avocadyne
0
Avocadyne 1-acetate
0
Avocadyne 2-acetate
0
Avocadyne 4-acetate
0
Baulamycin A
0
Baulamycin B
0
Benquinol
0
Bupleuonol
0
CJ-13,104
0
Chivotriene
0
Cicutoxin
0
Cystochromone C
0
DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
0
DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
0
DG(15:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
0
DG(18:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
0
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/16:0/0:0)
0
Daldispone B
0
Dehydrofalcarinol
0
Dehydrosafynol
0
Dihydropanaxacol
0
E-975
0
Enanthotoxin
0
Erythro-6,8-Tricosanediol
0
F-36316 B
0
F-36316 C
0
Ginsenoyne C
0
Ginsenoyne J
0
Ginsenoyne K
0
Hansfordiol A
0
Hansfordiol C
0
Hansfordiol D
0
Hansfordiol E
0
Hansfordiol G
0
Haplofungin A
0
Haplofungin B
0
Haplofungin C
0
Haplofungin D
0
Haplofungin E
0
Haplofungin F
0
Haplofungin G
0
Haplofungin H
0
Harzianumol G
0
Harzianumol H
0
Henicosane-6,8-diol
0
Hyafurone A1
0
Hyafurone A2
0
Hyafurone B
0
Hyapyrone A
0
Hyapyrone B
0
Hygrophoron B14
0
Hygrophorone A12
0
Hygrophorone B14
0
Hygrophorone B16
0
Hygrophorone F12
0
Hygrophorone G12
0
Isomurolic acid
0
LSM-4429
0
Leptolyngbyalide B
0
Leptolyngbyalide C
0
Linfuranone B
0
Linfuranone C
0
Linieodolide A
0
Loseolamycin A2
0
Macrolactin U
0
Marinisporolide A
0
Merulinic acid B
0
Methyl (2E)-2-(1-hydroxy-2-oxopropyl)-2-hexadecenoate
0
Methyl-[12]-gingerdiol
0
Momordol
0
Muricatacin
0
Murolic acid
0
Panaxjapyne A
0
Panaxjapyne B
0
Panaxjapyne C
0
Panaxynol
9
Panaxytriol
0
Penicilloitin B
0
Penitalarin B
0
Penitalarin C
0
Penixylarin C
0
Penostatin E
0
Persediene
0
Persenone A
0
Persenone B
0
Persenone C
0
Persin
0
Phanerosporic acid
0
Phomopoxide A
0
Phomopoxide B
0
Phomopoxide D
0
Phomopoxide E
0
Protoconstipatic acid
0
Ratjadone B
0
Ratjadone C
0
SNF-4794-7
0
SNF-4794-9
0
Safynol
0
Separacene A
0
Separacene B
0
Separacene C
0
Separacene D
0
Seselidiol
0
Succinilene A
0
Succinilene B
0
Succinilene C
0
Succinilene D
0
TM-124
0
Tanikolide
0
Tetrahydropersin
0
Trihazone B
0
Trihazone E
0
Virol A
0
Virol B
0
Z-10-Pentadecenol
0
[(2R)-2,3-dihydroxypropyl] (2E,4E,8E,13S)-13-hydroxytetradeca-2,4,8-trienoate
0
[(2S)-2,3-dihydroxypropyl] (2E,4E,8E,13S)-13-hydroxytetradeca-2,4,8-trienoate
0
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate
0
cis-Annonacin-10-one
0
fatty alcohol 13:0 +
0
fatty alcohol 13:1
0
fatty alcohol 14:0 +
0
fatty alcohol 14:1
0
fatty alcohol 15:0 +
0
fatty alcohol 15:1
0
fatty alcohol 16:0 +
0
fatty alcohol 16:1
0
fatty alcohol 17:0 +
0
fatty alcohol 17:1
0
fatty alcohol 18:0 +
21
fatty alcohol 18:1 +
0
fatty alcohol 18:2 +
0
fatty alcohol 18:3
0
fatty alcohol 19:0 +
0
fatty alcohol 20:0 +
0
fatty alcohol 20:1 +
0
fatty alcohol 20:2
0
fatty alcohol 21:0 +
0
fatty alcohol 22:0 +
0
fatty alcohol 22:1 +
0
fatty alcohol 22:2
0
hentriacontan-16-ol
0
iso-1,2-nonadecanediol
0
long-chain primary fatty alcohol +
31
methyl-2,3,5-trihydroxytetradecanoate
0
panaquinquecol 1
0
tridecanol +
0